RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Achalasia: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
EsoEinstein: A Multimodal AI System Integrating EGD and FLIP for Esophageal Motility Assessment.
Kaklamanos Evandros et al., Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (17 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42892386/
- 2.
Two pediatric type II achalasia cases complicated by candidal and eosinophilic esophagitis: Successful peroral endoscopic myotomy treatment.
Rotondo Fabio et al., JPGN reports (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42889764/
- 3.
Artificial Intelligence in Peroral Endoscopic Myotomy: Current Evidence, Limitations, and Future Directions
MD Ahmed Abdallah Salman et al., Gazi Medical Journal (15 October 2026)
https://doi.org/10.12996/gmj.2026.4723
- 4.
Pharmacobezoar: An Unexpected Cause of Dysphagia in a Patient With Treated Achalasia.
Ahuja Roma N et al., The American journal of gastroenterology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42877951/
- 5.
Reply to "Risk-Adapted Endoscopic Follow-Up After Achalasia: A Clinical Consideration".
Leijonmarck Wilhelm et al., Gastroenterology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42880670/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Achalasia
Achalasia is a rare disorder of the oesophagus that makes it difficult to swallow food and liquids. It occurs when the nerves in the oesophagus become damaged, preventing normal muscle movement and lower sphincter relaxation. Treatment options include endoscopic and surgical procedures, with active research into long-term outcomes.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
BACKGROUND & AIMS: Achalasia diagnosis relies on integrating endoscopic, functional, and physiologic testing, yet high-resolution manometry (HRM) is invasive, uncomfortable, and resource limited. Artificial intelligence (AI) offers a potential pathway to streamline this workflow. This study aimed to develop and validate AI models for diagnosing achalasia using esophagogastroduodenoscopy (EGD), Functional Lumen Imaging Probe (FLIP) panometry, and their combined multimodal integration, using Chicago Classification v4.0 (CCv4.0) as the reference standard. METHODS: In this retrospective study, 1,802 adult patients who underwent HRM and had available EGD and/or FLIP data at a tertiary center were included. Separate deep learning models were trained for EGD videos, FLIP heatmap images, and a multimodal transformer that integrated both modalities. Primary outcomes were sensitivity, specificity, and AUC for detecting achalasia. RESULTS: The 1,802-patient cohort was partitioned into training (n=1,522), validation (n=212), and test sets (n=68) for model development and evaluation. For the test set, the EGD model achieved sensitivity 0.724, specificity 0.974, and AUC 0.908. FLIP achieved sensitivity 0.862, specificity 0.821, and AUC 0.931. The multimodal model performed the best, with sensitivity 0.931, specificity 0.846, and AUC 0.969. Cochran's Q test found no statistically significant differences across models. CONCLUSION: Multimodal AI that integrates endoscopic and FLIP data achieves expert-level accuracy and has potential as a less invasive approach for diagnosing achalasia. To realize this potential, future work must validate the system in real-world settings to evaluate its impact on diagnostic timelines and longitudinal patient outcomes.
Common Questions
What is Achalasia?
Achalasia is a rare disorder of the oesophagus that makes it difficult to swallow food and liquids. It occurs when the nerves in the oesophagus become damaged, preventing normal muscle movement and lower sphincter relaxation. Treatment options include endoscopic and surgical procedures, with active research into long-term outcomes.
How many clinical trials are available for Achalasia?
RareWays currently indexes 98 clinical trials for Achalasia, of which 13 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Achalasia come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Achalasia.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.